CAH on XNYS, Wholesale Trade, Cardinal Health, Inc., job postings
Measures activity, not value. Not investment advice.
Shares gained 31% in a year as revenue rose 10% to $257.8B.
GoodNet income rose 14% to $1.8B over the last 12 months
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $67.5B, net income $554.0M.
31 Dec 2021RevenueNet incomeNet losstallest bar $67.5B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$67.5B
$554.0M
31 Dec 2025
$65.6B
$467.0M
30 Sep 2025
$64.0B
$450.0M
30 Jun 2025
$60.2B
–
31 Mar 2025
$54.9B
$506.0M
31 Dec 2024
$55.3B
$400.0M
30 Sep 2024
$52.3B
$416.0M
30 Jun 2024
$59.7B
–
31 Mar 2024
$54.9B
$258.0M
31 Dec 2023
$57.4B
$353.0M
30 Sep 2023
$54.8B
$5.0M
30 Jun 2023
$53.5B
-$64.0M
31 Mar 2023
$50.5B
$345.0M
31 Dec 2022
$51.5B
-$130.0M
30 Sep 2022
$49.6B
$110.0M
30 Jun 2022
$47.1B
$138.0M
31 Mar 2022
$44.8B
-$1.4B
31 Dec 2021
$45.5B
$49.0M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$257.8B
$234.3B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+10%
+6.4%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$1.8B
$1.6B
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$7.73
$6.63
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
3.9%
3.7%
10.3%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
1.0%
1.0%
-0.6%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
0.7%
0.7%
-8.5%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
–
7.9%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$4.9B
$4.5B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$5.3B
$4.6B
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$8.8B
$9.0B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$3.6B
$4.4B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
0.59
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
–
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
34.7
18.8
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
0.24
0.30
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
0.26
0.30
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
–
1.9
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
0.75%
1.4%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+1.0%
1,479 13F filers vs 1,465
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
87%
200.5M shares held by 13F filers (30 Sep 2026) of 231.1M outstanding (31 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
3.3%
7.6M shares sold short (30 Oct 2026) of 231.1M outstanding (31 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
4.2
7.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-1.3%
7.7M shares sold short in the report before, 7.6M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
52%
52% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 48%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
+31%
168 vs 128 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+5.5%
$67.5B vs $64.0B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+45%
$157.0M vs $108.0M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$52.9M
the 12 months before: $54.6M
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$3.1M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
45
45 articles in the last 7 days; its usual week has 5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
9.0×
45 articles in the last 7 days; its usual week has 5.
Unusual now sharp changes in the last 90 days, compared with its own past
Federal obligations $17.9M, 1.1× a year earlier
Price $272.81 on 20 Nov 2026, +31% over 12 months (12-month range $182.50 to $283.85)
Sharp change
8-K and other filings
WARN layoff notice
Lobbying filing
Insider net buying (open market). Insiders sold a net $61.6M in the last 12 months (the 12 months before: -$50.9M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 168 published in the last 12 months, +34% on the 12 months before.Revenue per quarter. Revenue $67.5B in the latest quarter, +5.5% on a year earlier.Capital spending per quarter. Capital spending $157.0M in the latest quarter, +45% on a year earlier.Institutional holders (13F filers). 1,479 13F filers reported holding it in the latest 13F quarter, +27% on a year earlier.Federal obligations. Federal obligations: $77.2M published in the last 12 months, +45% on the 12 months before.Lobbying spend. Lobbying spend: $3.1M published in the last 12 months, +13% on the 12 months before.Workers in WARN layoff notices. Workers in WARN layoff notices: 0 published in the last 12 months.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source.
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR TASK ORDER W81K0026FA040. FY26 PR# 0012284805.
Reported lobbying spend: $420K in Q3 2026, $476K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
30 Jun 2026
Ended
Twenty-First Century Group, Inc.for Cardinal Health, Inc.
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain.; Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain.; Tariff-related matters regarding the distribution and sale of pharmaceutical and medical products and the healthcare supply chain.Health issues, Pharmacy, DIS, Budget, TAR
Brownstein Hyatt Farber Schreck, LLPfor Cardinal Health, Inc.
General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages.Health issues
Two or more unrelated kinds of records unusual within 30 days
28 Oct 2022confirmed
Confirmed across sources Institutional holdings and Layoff notices and Short interest and volume
Cardinal Health(CAH): filed a WARN layoff notice covering 236 workers within 30 days; it also had 15.1M shares sold short in the 14 Oct 2022 report, 2.2× the same report last year; and it saw 95 13F filers open a new position in the quarter ended 30 Sep 2022, 1.9× the same quarter last year. Three unrelated kinds of activity within 28 days.
Short interest and volume: Short interest spike, became public on 13 Oct 2022
Layoff notices: WARN layoff notice, became public on 28 Oct 2022
Short interest and volume: Short interest spike, became public on 26 Oct 2022
Institutional holdings: Many funds opening a new position, became public on 14 Nov 2022
Short interest and volume: Short interest spike, became public on 10 Nov 2022
The 14 Oct 2022 report against the 24 reports before it.
this reportearliernormal: 6.7MSee the evidence (5 changes)
Short interest and volume: Short interest spike became public on 13 Oct 2022
Cardinal Health had 16.5M shares sold short in the 30 Sep 2022 report, 2.7× the same report last year.
This period
16.5M (the 30 Sep 2022 report)
Normal report (median of 24 earlier)
6.7M
Typical spread (median absolute deviation)
658K
How far from its usual level
+10.0
Same report last year
6.1M
History used
1,736 days
the 30 Sep 2022 report24 earlier reportsnormal: 6.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Short interest and volume: Short interest spike became public on 26 Oct 2022
Cardinal Health had 15.1M shares sold short in the 14 Oct 2022 report, 2.2× the same report last year.
This period
15.1M (the 14 Oct 2022 report)
Normal report (median of 24 earlier)
6.7M
Typical spread (median absolute deviation)
658K
How far from its usual level
+8.5
Same report last year
6.8M
History used
1,750 days
the 14 Oct 2022 report24 earlier reportsnormal: 6.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Nov 2022
Cardinal Health saw 95 13F filers open a new position in the quarter ended 30 Sep 2022, 1.9× the same quarter last year.
This period
95 (the quarter ended 30 Sep 2022)
Normal quarter (median of 8 earlier)
68.5
Typical spread (median absolute deviation)
4
How far from its usual level
+3.9
Same quarter last year
49
History used
3,287 days
the quarter ended 30 Sep 20228 earlier quartersnormal: 68.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 10 Nov 2022
Cardinal Health had 11.9M shares sold short in the 31 Oct 2022 report, 1.4× the same report last year.
This period
11.9M (the 31 Oct 2022 report)
Normal report (median of 24 earlier)
6.8M
Typical spread (median absolute deviation)
650K
How far from its usual level
+5.3
Same report last year
8.2M
History used
1,767 days
the 31 Oct 2022 report24 earlier reportsnormal: 6.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
19 Feb 2019confirmed
Confirmed across sources Institutional holdings and Lobbying
Cardinal Health(CAH): reported $970K of lobbying spend for the quarter ended 31 Dec 2018, 1.9× the same quarter last year, while it saw 86 13F filers open a new position in the quarter ended 31 Dec 2018, 1.7× the same quarter last year. Two unrelated kinds of activity within 28 days.
Lobbying: Lobbying spend jump, became public on 22 Jan 2019
Institutional holdings: Many funds opening a new position, became public on 14 Feb 2019
The quarter ended 31 Dec 2018 against the 8 quarters before it.
this quarterearliernormal: $510KSee the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 22 Jan 2019
Cardinal Health reported $970K of lobbying spend for the quarter ended 31 Dec 2018, 1.9× the same quarter last year.
This period
$970K (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
$510K
Typical spread (median absolute deviation)
$85K
How far from its usual level
+3.7
Same quarter last year
$520K
History used
2,649 days
the quarter ended 31 Dec 20188 earlier quartersnormal: $510K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Institutional holdings: Many funds opening a new position became public on 14 Feb 2019
Cardinal Health saw 86 13F filers open a new position in the quarter ended 31 Dec 2018, 1.7× the same quarter last year.
This period
86 (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
52.5
Typical spread (median absolute deviation)
4
How far from its usual level
+5.6
Same quarter last year
51
History used
1,918 days
the quarter ended 31 Dec 20188 earlier quartersnormal: 52.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
booked $17.9M in federal contract and grant obligations in October 2026, 1.1× the same month last year.
Same month last year: $16.9M; its normal month is $852K.
See the evidence
This period
$17.9M (October 2026)
Normal month (median of 5 earlier)
$852K
Typical spread (median absolute deviation)
$438K
How far from its usual level
+17.0
Same month last year
$16.9M
History used
6,970 days
October 20265 earlier monthsnormal: $852K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
had 21 H-1B/E-3 visa applications certified in November 2025, 2.3× the same month last year.
Same month last year: 9; its normal month is 9.
See the evidence
This period
21 (November 2025)
Normal month (median of 5 earlier)
9
Typical spread (median absolute deviation)
1
How far from its usual level
+4.0
Same month last year
9
History used
2,252 days
November 20255 earlier monthsnormal: 9
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
saw 192 13F filers open a new position in the quarter ended 31 Dec 2025, 1.9× the same quarter last year.
Same quarter last year: 102; its normal quarter is 100.
See the evidence
This period
192 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
100
Typical spread (median absolute deviation)
17
How far from its usual level
+3.6
Same quarter last year
102
History used
4,475 days
the quarter ended 31 Dec 20258 earlier quartersnormal: 100
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Showing the newest 40 of 156 entries; narrow the window or the kind of data to see older ones.
Not listed: 177 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000721371
Ticker
CAH
Domain
cardinalhealth.com
Employer name
Cardinal Health, CARDINAL HEALTH 200 (2 unverified)
Hq location
OH|DUBLIN|43017 (1 unverified)
Lobbying client
cardinal health, cardinal health fka the glover park group, griffin capital, quarles and brady llp on behalf of cardinal health and 1 more
Name
Aero-Med, LLC, Allegiance Corporation, A+ Secure Packaging, LLC, CARDINAL DISTRIBUTION INC and 116 more
Uei
CWN9UGL3NCL9, M2HTNCUTA4K9, N25KC4APTJ98, S1F4H93MPFT9 and 2 more
Wikidata
Q902397
Wikipedia
Cardinal Health
DOL H-1B labor condition applications and PERM certifications1685 data points1 Oct 2019 to 28 Sep 2026
Federal lobbying disclosures (LDA)41 records, 276 data points1 Sep 1999 to 30 Sep 2026
SEC Form 13F institutional holdings2 records, 481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)158 records1 Feb 2016 to 5 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1080 data points30 Jun 2007 to 31 Oct 2026
SEC Form 4 insider transactions58 records, 132 data points23 May 2016 to 20 Aug 2026
FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards36 records, 19755 data points1 Oct 2007 to 20 Nov 2026
WARN layoff notices (state labor agencies)5 records, 15 data points12 Dec 2005 to 27 Oct 2022
Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026